Vifor (International) Ltd 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-18 5:10 pm Unchanged |
2024-12-17 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd | 616,398 13.500% |
0 (Unchanged) |
Filing |
| 2024-10-30 4:21 pm Unchanged |
2024-10-23 | 13D | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd | 616,398 13.500% |
0 (Unchanged) |
Filing |
| 2023-07-25 4:40 pm Unchanged |
2023-07-25 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd | 616,398 13.700% |
0 (Unchanged) |
Filing |
| 2021-10-21 4:15 pm Purchase |
2021-10-20 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd | 616,398 13.900% |
273,533 (+79.78%) |
Filing |
| 2020-10-23 4:05 pm Purchase |
2020-10-15 | 13G | Cara Therapeutics, Inc. CARA |
Vifor (International) Ltd | 342,865 8.300% |
342,865 (New Position) |
Filing |